Ocata Therapeutics Inc fka OCAT

[Wopsal101]

It's very difficult to disagree with your logic. The problem is if you wait to invest until the company can generate revenue, you will have likely missed the most lucrative investment period. There are some things in the pipe line that offer substantial opportunity (Platelets, blood, RPE). Not to mention NIH approval of ACT stem cell lines. There are several opportunities for ACT. One of the opportunities that was available I am sure is the opportunity to partner in China. Given the track record of Chinese partnerships this would have been a bad choice. I congratulate whomever convinced Gary not to do this. Could it have provided upfront money, absolutely. Could you have lost your technology? Possibly. Without the ability to ship the cells to a Chinese partner, this would have been a death sentence. Was it a mistake to bring it up. Yes. No different then bringing up a partner for the platelet program. However I believe in the next six months we will begin to see some of these problems fixed. The question is what is the technology worth? Does it work? That's what this will really come down too.